H—UPPP术后镇痛方式的选择及临床效果观察(3)
[8] Zabora J，BrintzenhofeSzoc K，Curbow B，et al.The Prevalence of Psychological Distress by Cancer Site[J].Psychooncology，2001，10(1)：19-28.
[9] Mitchell A J.Short Screening Tools for Cancer-Related Distress：A Review and DiagnostiValidity Meta-Analysis[J].J Natl Compr Canc Netw，2010，8(4)：487-494.
[10] Watson A J，Nicol L，Donaldson S，et al.Complications of Stomas：Their Aetiology and Management[J].Br J Community Nurs，2013，18(3)：111-112，114，116.
[11] Myasoedova E，Crowson C，Kremers H，et al.Is the Incidence of Rheumatoid Arthritis Rising？ Results from Olmsted County，Minnesota，1955-2007[J].Arthritis Rheum，2010，62(6)：1576-1582.
[12] Horton S C，Walsh C A，Emery P.Estabished Rheumatoid Arthritis：Rationale for Best Practice：Physicians’ Perspective of How to Realize Tight Control in Clinical Practice[J].Best Pract Res Clin Rheumatol，2011，25(4)：509-521.
[13] Maini R N，Breedveid F C，Kalden J R，et al.Sustained Improvement over Two Years in Physical Function，Structural Damage，and Signs and Symptoms among Patients with Rheu-matoid Arthritis T Reated with Infliximab and Methotrexate[J].Arthritis Rheum，2004，50(4)：1051-1065.
[14] Navarro-Millán I，Singh J A，Curtis J R.Systematic Review ofTocilizumab for Rheumatoid Arthritis：A New Biologic Agent Targeting the Interleukin-6 Receptor[J].Clin Ther，2012，34(4)：788-802.
[15] Koike R，Harigai M，Atsumi T，et al.Japan College of Rheumatology 2009 Guidelines for the Use of Tocilizumab，a Humanized Anti-interleukin-6 Receptor Monoclonal Antibody，in Rheumatoid Arthritis[J].Mod Rheumatol，2009，19(4)：351-357.
[16] Furst D E，Keystone E C，Braun J，et al.Updated Consensus Statement on Biological Agents for the Treatment of Rheumatic Diseases，2011[J].Ann Rheum Dis，2012，71(Suppl 2)：2-45.
[17] Dev R，Dalal S，Bruera E.Is There a Role for Parenteral Nutrition or Hydration at the End of Life？[J].Curr Opin Support Palliat Care，2012，6(3)：365-370.
[18] Galanakis C，Mayo N E，Gagnon B.Assessing the Role of Hydration in Delirium at the End of Life[J].Curr Opin Support Palliat Care，2011，5(2)：169-173.
[19] Leung W K，Ho K Y，Kim W H，et al.Colorectal Neoplasia in Asia：A Multicenter Colonoscopy Survey in Symptomatic Patients[J].Gastrointest Endosc，2006，64(5)：751-759.
[20] Marks P W.Update in Hematology and Oncology：Evidence Published In 2013[J].Ann Intern Med，2014，32(8)：214-215.
(收稿日期：2018-05-09) (本文編辑：董悦), 百拇医药(叶兰)
[9] Mitchell A J.Short Screening Tools for Cancer-Related Distress：A Review and DiagnostiValidity Meta-Analysis[J].J Natl Compr Canc Netw，2010，8(4)：487-494.
[10] Watson A J，Nicol L，Donaldson S，et al.Complications of Stomas：Their Aetiology and Management[J].Br J Community Nurs，2013，18(3)：111-112，114，116.
[11] Myasoedova E，Crowson C，Kremers H，et al.Is the Incidence of Rheumatoid Arthritis Rising？ Results from Olmsted County，Minnesota，1955-2007[J].Arthritis Rheum，2010，62(6)：1576-1582.
[12] Horton S C，Walsh C A，Emery P.Estabished Rheumatoid Arthritis：Rationale for Best Practice：Physicians’ Perspective of How to Realize Tight Control in Clinical Practice[J].Best Pract Res Clin Rheumatol，2011，25(4)：509-521.
[13] Maini R N，Breedveid F C，Kalden J R，et al.Sustained Improvement over Two Years in Physical Function，Structural Damage，and Signs and Symptoms among Patients with Rheu-matoid Arthritis T Reated with Infliximab and Methotrexate[J].Arthritis Rheum，2004，50(4)：1051-1065.
[14] Navarro-Millán I，Singh J A，Curtis J R.Systematic Review ofTocilizumab for Rheumatoid Arthritis：A New Biologic Agent Targeting the Interleukin-6 Receptor[J].Clin Ther，2012，34(4)：788-802.
[15] Koike R，Harigai M，Atsumi T，et al.Japan College of Rheumatology 2009 Guidelines for the Use of Tocilizumab，a Humanized Anti-interleukin-6 Receptor Monoclonal Antibody，in Rheumatoid Arthritis[J].Mod Rheumatol，2009，19(4)：351-357.
[16] Furst D E，Keystone E C，Braun J，et al.Updated Consensus Statement on Biological Agents for the Treatment of Rheumatic Diseases，2011[J].Ann Rheum Dis，2012，71(Suppl 2)：2-45.
[17] Dev R，Dalal S，Bruera E.Is There a Role for Parenteral Nutrition or Hydration at the End of Life？[J].Curr Opin Support Palliat Care，2012，6(3)：365-370.
[18] Galanakis C，Mayo N E，Gagnon B.Assessing the Role of Hydration in Delirium at the End of Life[J].Curr Opin Support Palliat Care，2011，5(2)：169-173.
[19] Leung W K，Ho K Y，Kim W H，et al.Colorectal Neoplasia in Asia：A Multicenter Colonoscopy Survey in Symptomatic Patients[J].Gastrointest Endosc，2006，64(5)：751-759.
[20] Marks P W.Update in Hematology and Oncology：Evidence Published In 2013[J].Ann Intern Med，2014，32(8)：214-215.
(收稿日期：2018-05-09) (本文編辑：董悦), 百拇医药(叶兰)